Home | Business News | Browse by Publication | B | Business Wire

Bradmer Pharmaceuticals Inc. Receives Final Approval for Qualifying Transaction.

Publication: Business Wire
Publication Date: 15-FEB-06
Format: Online
Delivery: Immediate Online Access

Article Excerpt
TORONTO -- - Bradmer to begin trading February 16th on the TSX Venture Exchange -

Bradmer Pharmaceuticals Inc. (TSX VENTURE:BMR.P), a capital pool company, announced today that it has received final approval from the TSX Venture Exchange for its recently completed Qualifying Transaction with Blue Devil Pharmaceuticals Inc. The completion of the Qualifying Transaction was previously announced in a press release of Bradmer dated February 10, 2006....

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from Business Wire
AXIS Capital Announces Trident Has Agreed to Sell 3,150,000 Shares in ..., February 16, 2006
SonoSite Reiterates Support for Abdominal Aortic Aneurysm (AAA) Screen..., February 16, 2006
Labor Ready Names Steve Cooper as Chief Executive Officer; Current CEO..., February 16, 2006
Quest Capital Corp.: AIM Market Listing., February 16, 2006
Skanska: Year-End Report, January-December 2005., February 16, 2006

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.